No Data
Guizhou Yibai Pharmaceutical (600594.SH): Currently, the company's major health products focus on throat lozenges, instant drinks, solid beverages, etc.
Gelonghui November 11th | Guizhou Yibai Pharmaceutical (600594.SH) stated on the investor interaction platform that the company's current anti-tumor products include injection of oxaliplatin, Kansai Di capsules, and Aiyu capsules. Currently, the company's large health products are mainly focused on throat lozenges, instant drinks, solid beverages, etc.
China Life Insurance has reached a strategic cooperation with Zenlin Daikang Health and Jianfa International Travel on cross-border residence and health care.
BOC Hong Kong (02388.HK) and BOC Group Life Insurance jointly participated in the 7th China International Import Expo silver economy theme series activities. At the event, BOC Life Insurance signed a strategic cooperation memorandum of understanding on cross-border residential health care with Zhenlin Health Holdings under Yee Lee Group in Macau, as well as Xiamen Jiande International Travel Agency Group (Jiande Guolv) . BOCC Life CEO Deng Ziping stated that BOCC Life will collaborate with BOC Hong Kong, leveraging the advantages of "banks + insurance", relying on BOC's global, integrated, and scenario-based resources and strengths, to cooperate and build a "comprehensive financial products + multi
Tianjin Ringpu Bio-technology (300119.SZ) plans to acquire 15% equity of Sino-Swiss Huapu to improve its strategic layout in the pet health industry.
Zhītōng Cái Jīn APP News, tianjin ringpu bio-technology (300119.SZ) announced that, in order to continuously improve the company's strategic layout in the pet health sector,...
Express News | Minsheng Health: actively seeking new project opportunities in the big health field that are in line with the company's development global strategy and have rich synergies upstream and downstream.
Express News | Moutai's fund is once again making a move, planning to increase its investment in the healthcare industry by 0.554 billion yuan.
Unihealth International [02211] is now trading at 0.147 Hong Kong dollars, up by 13.95%.
As of 13:21, uni health [02211] reported a price of 0.147 Hong Kong dollars, an increase of 0.018 Hong Kong dollars or 13.95% from the closing price of 0.129 Hong Kong dollars yesterday, with a turnover of 0.1336 million Hong Kong dollars. The highest price today is 0.142 Hong Kong dollars, and the lowest price is 0.117 Hong Kong dollars. Based on the closing price yesterday, the 10-day average price is 0.13 Hong Kong dollars, the 50-day average price is 0.08 Hong Kong dollars, and the current P/E ratio is 184.29 times, with a 14-day relative strength index of 66.67.
No Data
No Data